Literature DB >> 21810890

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

Katya Rascovsky1, John R Hodges, David Knopman, Mario F Mendez, Joel H Kramer, John Neuhaus, John C van Swieten, Harro Seelaar, Elise G P Dopper, Chiadi U Onyike, Argye E Hillis, Keith A Josephs, Bradley F Boeve, Andrew Kertesz, William W Seeley, Katherine P Rankin, Julene K Johnson, Maria-Luisa Gorno-Tempini, Howard Rosen, Caroline E Prioleau-Latham, Albert Lee, Christopher M Kipps, Patricia Lillo, Olivier Piguet, Jonathan D Rohrer, Martin N Rossor, Jason D Warren, Nick C Fox, Douglas Galasko, David P Salmon, Sandra E Black, Marsel Mesulam, Sandra Weintraub, Brad C Dickerson, Janine Diehl-Schmid, Florence Pasquier, Vincent Deramecourt, Florence Lebert, Yolande Pijnenburg, Tiffany W Chow, Facundo Manes, Jordan Grafman, Stefano F Cappa, Morris Freedman, Murray Grossman, Bruce L Miller.   

Abstract

Based on the recent literature and collective experience, an international consortium developed revised guidelines for the diagnosis of behavioural variant frontotemporal dementia. The validation process retrospectively reviewed clinical records and compared the sensitivity of proposed and earlier criteria in a multi-site sample of patients with pathologically verified frontotemporal lobar degeneration. According to the revised criteria, 'possible' behavioural variant frontotemporal dementia requires three of six clinically discriminating features (disinhibition, apathy/inertia, loss of sympathy/empathy, perseverative/compulsive behaviours, hyperorality and dysexecutive neuropsychological profile). 'Probable' behavioural variant frontotemporal dementia adds functional disability and characteristic neuroimaging, while behavioural variant frontotemporal dementia 'with definite frontotemporal lobar degeneration' requires histopathological confirmation or a pathogenic mutation. Sixteen brain banks contributed cases meeting histopathological criteria for frontotemporal lobar degeneration and a clinical diagnosis of behavioural variant frontotemporal dementia, Alzheimer's disease, dementia with Lewy bodies or vascular dementia at presentation. Cases with predominant primary progressive aphasia or extra-pyramidal syndromes were excluded. In these autopsy-confirmed cases, an experienced neurologist or psychiatrist ascertained clinical features necessary for making a diagnosis according to previous and proposed criteria at presentation. Of 137 cases where features were available for both proposed and previously established criteria, 118 (86%) met 'possible' criteria, and 104 (76%) met criteria for 'probable' behavioural variant frontotemporal dementia. In contrast, 72 cases (53%) met previously established criteria for the syndrome (P < 0.001 for comparison with 'possible' and 'probable' criteria). Patients who failed to meet revised criteria were significantly older and most had atypical presentations with marked memory impairment. In conclusion, the revised criteria for behavioural variant frontotemporal dementia improve diagnostic accuracy compared with previously established criteria in a sample with known frontotemporal lobar degeneration. Greater sensitivity of the proposed criteria may reflect the optimized diagnostic features, less restrictive exclusion features and a flexible structure that accommodates different initial clinical presentations. Future studies will be needed to establish the reliability and specificity of these revised diagnostic guidelines.

Entities:  

Mesh:

Year:  2011        PMID: 21810890      PMCID: PMC3170532          DOI: 10.1093/brain/awr179

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  169 in total

Review 1.  Behavior and treatment in frontotemporal dementia.

Authors:  R J Perry; B L Miller
Journal:  Neurology       Date:  2001-06       Impact factor: 9.910

2.  Tau is a candidate gene for chromosome 17 frontotemporal dementia.

Authors:  P Poorkaj; T D Bird; E Wijsman; E Nemens; R M Garruto; L Anderson; A Andreadis; W C Wiederholt; M Raskind; G D Schellenberg
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

3.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

4.  Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD.

Authors:  Howard J Rosen; K M Hartikainen; W Jagust; J H Kramer; B R Reed; J L Cummings; K Boone; W Ellis; C Miller; B L Miller
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

5.  Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's disease.

Authors:  Katya Rascovsky; David P Salmon; Lawrence A Hansen; Douglas Galasko
Journal:  J Int Neuropsychol Soc       Date:  2008-05       Impact factor: 2.892

6.  Frontal-executive versus posterior-perceptual mental status deficits in early-onset dementias.

Authors:  Mario F Mendez; Aaron M McMurtray; Eliot A Licht; Ronald E Saul
Journal:  Am J Alzheimers Dis Other Demen       Date:  2009-03-27       Impact factor: 2.035

7.  Behavioral differences between frontotemporal dementia and Alzheimer's disease: a comparison on the BEHAVE-AD rating scale.

Authors:  M F Mendez; K M Perryman; B L Miller; J L Cummings
Journal:  Int Psychogeriatr       Date:  1998-06       Impact factor: 3.878

8.  Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia.

Authors:  William W Seeley; Richard Crawford; Katya Rascovsky; Joel H Kramer; Michael Weiner; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Arch Neurol       Date:  2008-02

9.  Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.

Authors:  Anna R Giovagnoli; Alessandra Erbetta; Fabiola Reati; Orso Bugiani
Journal:  Neuropsychologia       Date:  2008-01-05       Impact factor: 3.139

10.  Relationship between positive and negative symptoms and neuropsychological scores in frontotemporal dementia and Alzheimer's disease.

Authors:  Kyle Brauer Boone; Bruce L Miller; Randolph Swartz; Po Lu; Alison Lee
Journal:  J Int Neuropsychol Soc       Date:  2003-07       Impact factor: 2.892

View more
  1403 in total

Review 1.  Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau.

Authors:  Keith A Josephs
Journal:  Mayo Clin Proc       Date:  2017-08       Impact factor: 7.616

2.  Greater Experience of Negative Non-Target Emotions by Patients with Neurodegenerative Diseases Is Related to Lower Emotional Well-Being in Caregivers.

Authors:  Kuan-Hua Chen; Jenna L Wells; Marcela C Otero; Sandy J Lwi; Claudia M Haase; Robert W Levenson
Journal:  Dement Geriatr Cogn Disord       Date:  2017-12-08       Impact factor: 2.959

3.  A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting.

Authors:  Andrea Vergallo; Cecilia Carlesi; Cristina Pagni; Filippo Sean Giorgi; Filippo Baldacci; Lucia Petrozzi; Roberto Ceravolo; Gloria Tognoni; Gabriele Siciliano; Ubaldo Bonuccelli
Journal:  Neurol Sci       Date:  2017-07-19       Impact factor: 3.307

4.  Papez Circuit Gray Matter and Episodic Memory in Amyotrophic Lateral Sclerosis and Behavioural Variant Frontotemporal Dementia.

Authors:  Ana Paula Arantes Bueno; Leonardo Cruz de Souza; Walter Hugo Lopez Pinaya; Antônio Lúcio Teixeira; Laura Godoy Rousseff de Prado; Paulo Caramelli; Michael Hornberger; João Ricardo Sato
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

Review 5.  Brain Banking for Research into Neurodegenerative Disorders and Ageing.

Authors:  Claire E Shepherd; Holly Alvendia; Glenda M Halliday
Journal:  Neurosci Bull       Date:  2019-01-02       Impact factor: 5.203

6.  Functional neural correlates of emotional expression processing deficits in behavioural variant frontotemporal dementia.

Authors:  Karim Virani; Sarah Jesso; Andrew Kertesz; Derek Mitchell; Elizabeth Finger
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

7.  Circulating progranulin as a biomarker for neurodegenerative diseases.

Authors:  Roberta Ghidoni; Anna Paterlini; Luisa Benussi
Journal:  Am J Neurodegener Dis       Date:  2012-08-02

Review 8.  Tauopathies as clinicopathological entities.

Authors:  David J Irwin
Journal:  Parkinsonism Relat Disord       Date:  2015-09-08       Impact factor: 4.891

Review 9.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

10.  Clinicopathologic differences among patients with behavioral variant frontotemporal dementia.

Authors:  Mario F Mendez; Aditi Joshi; Kanida Tassniyom; Edmond Teng; Jill S Shapira
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.